Author: 0526bmf1980

For this edition of The Onco’Zine Brief, recorded during 59th annual meeting of the American Society of Hematology held December 9 to 12, 2017 in Atlanta, Georgia, Peter Hofland and Sonia Portillo, the team behind show, sat down with Steven E. Benner,…

In this edition of The Onco’Zine Brief, recorded during the 59th annual meeting of the American Society of Hematology – held December 9 to 12, 2017 in Atlanta, Georgia (USA), we talk with Anna Sureda, MD, Ph.D, Head of the Hematology Department at the…

In this episode Peter Hofland and Sonia Portillo, the team behind The Onco’Zine Brief, talk with Angela M. DeMichele, MD MSCE, Professor of Medicine and Epidemiology at the Perelman School of Medicine at the University of Pennsylvania.

Over the last…

In this episode of The OncoZine Brief Peter Hofland interviews Darrin Uecker and Richard Nuccitelli of Pulse Biosciences.

The team at Pulse Biosciences has developed a technology is called Nano-pulse Stimulation, or NPS. This novel technology…

In this episode of The Onco’Zine Brief Peter Hofland and Sonia Portillo talk with Michael A. Caligiuri, MD, the current (2017- 2018) president of the American Association for Cancer Research | AACR.

Caligiuri is director of The Ohio State University…

Born and raised in Curaçao NA, an island in the southern Caribbean Sea, Bob Pinedo, MD, PhD, now professor emeritus and a consultant to the Board of the Free University Medical Center in Amsterdam, The Netherlands, remains a real powerhouse in the…

In this episode of The Onco’Zine Brief Peter Hofland and Sonia Portillo interview Nancy Brinker, founder of Susan G. Komen for the Cure.

This program was originally recorded during the Annual Meeting of the American Association of Cancer Research -…

Recorded during the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO), Peter Hofland and Sonia Portillo, the team behind The Onco’Zine Brief, interview Dr. Robert Andtbacka, associate professor in the Division of Surgical…

Patients living with invasive breast cancer with high levels of HER3 may face a significantly worse prognosis and decreased survival. This represents a large unmet medical need.

Overexpression of epidermal growth factor receptors, also known as EGFR,…

For this edition of The OncoZine Brief, Peter Hofland and Sonia Portillo sat down with Jonathan E. Lim, M.D. co-founder of IGNYTA, and its President and Chief Executive Officer since July 2012.

Lim is the Founder and Managing Partner at City Hill…

Recorded during the 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO), held June 2 – 6, 2017 in Chicago, Ill, Sonia Portillo and Peter Hofland, the team behind The Onco’Zine Brief, interview Dr. Steve Benner – Senior Vice…

In this episode of The Onco’Zine Brief Peter Hofland and Sonia Portillo talk with Alice Crisci.

Alice is a cancer survivor.

As part of her journey to survival Crisci founded Fertile Action, a cancer charity established to ensure fertile people…

Each year, 1.4 million people are diagnosed with lung cancer worldwide. The 5-year survival rate for these patients is only 15.9%.

In this episode of the Peter Hofland and Sonia Portillo, the team behind The Onco’Zine Brief, interview Bonnie Adario,…

In this episode of The Onco’Zine Brief, Peter Hofland and Sonia Portillo, talk with David R. Epstein B.Sc, MBA, the Executive Chairman of Rubius Therapeutics.

Epstein explains how his company is pioneering novel Red-Cell Therapeutics or RCTs –…

Lung cancer remains one of the most frequently diagnosed cancers. It is also one of the deadliest cancers – with each year more than 1.6 million tumor-related deaths worldwide.

The correlation between smoking and mortality from lung cancer has been…

In this episode of The Onco’Zine Brief, Peter Hofland and Sonia Portillo talk with Robert Z. Orlowski, MD, PhD, chairman, Ad Interim, Director of Myeloma and Professor of Medicine in the Departments of Lymphoma, Myeloma and Experimental Therapeutics…

In this episode of The Onco’Zine Brief, recorded during CPhI World Wide, held October 24 – 27, 2017 in Frankfurt, Germany, Peter Hofland and Sonia Portillo, interview Charlie Johnson, the CEO of ADC Bio.

ADC Bio, a biotechnology company developing…

Even modest use of alcohol may increase cancer risk. The greatest risks are observed with heavy, long-term use of alcohol. Now, for the first time, the American Society of Clinical Oncology (ASCO) has formally recognized that alcohol drinking is a…